Silicon Valley pro studies do-it-yourself clinical trials

We've heard of biotech startups birthed in garages, but what about clinical trials? Silicon Valley investment advisor Melanie Swan has penned an article in the journal Personalized Medicine that offers steps to boost the professionalism of do-it-yourself (DIY) clinical trials, and part of her solution involves online collaboration. Swan was among those who took part in a DIY study that sought to find the ultimate type of vitamin B supplement for lowering a biomarker associated with heart disease risk, The Wall Street Journal reported. Now she's rubbing elbows with elite scientists to advance DIY clinical trials. It should be interesting to see what amateur clinical investigators come up with, as drugmakers have struggled to find the perfect recipe for getting trials done right. Article

 

 

Suggested Articles

The new solution aims to streamline the incorporation of human genomic data into clinical trial designs.

TriNetX's platform uses EHR data to help drug developers with clinical trial protocol design and study site and participant identification.

The $58 million financing round represents biopharma industry's growing interest in genomics data.